Research Solutions, Inc. — Form 10-K Summary
Reporting period: Fiscal year ended June 30, 2023, with comparison to fiscal 2022. The filing also reports the quarter ended June 30, 2023 (fiscal Q4); this is not a 2022 Q4 filing.
Business context
Research Solutions provides cloud-based SaaS research platforms and delivers published scientific, technical and medical articles through individual transactions. Its customers include life-science companies, academic institutions and other research-intensive organizations. FY2023 revenue growth reflected platform deployments and expansion, higher paid article-order volume and pricing initiatives, and the FIZ asset acquisition, effective January 1, 2023.
Key financial results
| Metric | FY2023 | FY2022 |
|---|---|---|
| Revenue | $37.70 million | $32.93 million |
| Gross profit / gross margin | $14.70 million / 39.0% | $12.02 million / 36.5% |
| Operating income (loss) | $238,608 | $(1.63) million |
| Net income (loss) | $571,623 | $(1.63) million |
| Adjusted EBITDA | $2.02 million | $(374,000) |
| Cash from operations | $3.38 million | $(417,200) |
| Cash and cash equivalents at year-end | $13.55 million | $10.60 million |
- Platform revenue increased 27.9% to $8.68 million; transaction revenue increased 11.0% to $29.02 million.
- Operating expenses rose 5.9% to $14.46 million, including a 68.7% increase in stock-based compensation to $1.85 million.
- FY2023 net margin was approximately 1.5%, compared with a net loss in FY2022. Adjusted EBITDA is a non-GAAP measure and should not be viewed as a substitute for GAAP results or operating cash flow.
- For the quarter ended June 30, 2023, revenue was $9.96 million versus $8.56 million a year earlier; net income was $375,746 versus a net loss of $438,267.
Liquidity, debt and cash flow
- At June 30, 2023, current assets were $21.30 million and current liabilities were $14.50 million, implying working capital of about $6.80 million. The company reported no outstanding borrowings under its revolving credit facility.
- The secured Silicon Valley Bank line of credit had a $2.5 million maximum (subject to eligible receivables), approximately $2.264 million available at year-end, a 9.25% interest rate and a February 28, 2024 maturity. The company was in covenant compliance at year-end.
- Operating cash flow benefited in part from higher accounts payable and accrued expenses, deferred revenue, and noncash stock-based compensation; accounts receivable growth was a partial offset.
- Investing cash use was $344,659, including a $297,450 non-refundable FIZ acquisition deposit. Financing cash use was $97,259, including $104,250 of share repurchases and $50,509 of contingent acquisition consideration, partly offset by option-exercise proceeds.
Changes, outlook and risks
- Gross margin improved by 2.5 percentage points, while operating expenses increased more slowly than revenue. Profitability and operating cash flow improved substantially from FY2022, though the company reports a $22.52 million accumulated deficit and cautions it may not sustain profitability.
- The FIZ asset acquisition transferred certain AutoDoc customer contracts. On July 28, 2023, the company acquired Resolute Innovation, an AI- and NLP-powered search and knowledge-management platform, for approximately $2.9 million net of cash acquired, with an earnout tied to future recurring revenue.
- No quantified revenue or earnings guidance is provided. Management describes growth priorities including customer expansion, product development, new markets and selective acquisitions.
- Key risks include dependence on a small number of content suppliers (three suppliers represented approximately 43% of content costs), competition and piracy, technology and cybersecurity disruption, access to capital, foreign-currency exposure, and the ability to maintain profitability. The company held $7.58 million at SVB at year-end, estimated $6.443 million above government-insured limits, and was diversifying banking relationships.
- Legal proceedings are described as ordinary-course matters that management does not expect to have a material financial-statement effect. The independent auditor issued an unqualified opinion; revenue recognition for single-article transactions was identified as a critical audit matter. Management concluded disclosure controls and internal control over financial reporting were effective; the auditor did not audit internal controls.
Investor verification priorities
- Confirm the sustainability and underlying drivers of the return to GAAP profitability and positive operating cash flow.
- Assess whether platform growth, transaction volumes and improved gross margins can continue, including the contribution and costs of the FIZ contracts.
- Review the Resolute Innovation acquisition consideration, earnout terms, integration progress and subsequent financial impact.
- Monitor the credit-line maturity, covenant requirements, banking diversification and uninsured cash exposure.
- Evaluate supplier concentration, stock-based compensation and potential dilution; 2.91 million options and 2.48 million unvested restricted shares were outstanding at year-end.